Avanafil Tablets
formulated to address erectile dysfunction intended to support sexual performance.
Strengths: 50 · 100 · 200mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Spedra
- Therapeutic class
Phosphodiesterase-5 Inhibitor
- Pharmacological class
PDE5 Inhibitor
- Minor side effects
headache; flushing; nasal congestion
- Moderate side effects
dizziness; back pain; dyspepsia
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Menarini
- Onset Time
15–30 minutes
- Duration
6–12 hours
- Storage instructions
Store below 30°C in the original packaging.
- Drug interactions
nitrates; alpha-blockers; grapefruit juice
- Age restrictions
Not indicated for those under 18.
- Pregnancy and breastfeeding
Not applicable.
Contraindications
hypersensitivity; concurrent use of nitrates; severe cardiovascular disease; severe hepatic impairment
Precautions and warnings
seek medical help if erection persists beyond four hours; caution in patients with anatomical penis deformation
Serious side effects
priapism — requires immediate medical attention; sudden vision loss — requires immediate medical attention
Patient summary
formulated to address erectile dysfunction intended to support sexual performance.
Mechanism of action
Avanafil is a highly selective phosphodiesterase-5 inhibitor that increases cyclic guanosine monophosphate (cGMP) levels in the corpus cavernosum, facilitating smooth muscle relaxation and enhanced penile blood flow during sexual stimulation.
Avanafil Tablets
formulated to address erectile dysfunction intended to support sexual performance.
Editorial Notes
- Active ingredient(s): Avanafil
- Listed indication(s): Erectile Dysfunction
Usually available as
- 36 tablets - 50 mg1374-50-mg-16495
- 24 tablets - 100 mg1374-100-mg-16500
- 24 tablets - 200 mg1374-200-mg-16490